EPIC-Survival: End-to-end Part Inferred Clustering for Survival Analysis, Featuring Prognostic Stratification Boosting

• URL: http://arxiv.org/abs/2101.11085v2
• Date: Thu, 28 Jan 2021 21:30:38 GMT
• Title: EPIC-Survival: End-to-end Part Inferred Clustering for Survival Analysis, Featuring Prognostic Stratification Boosting
• Authors: Hassan Muhammad, Chensu Xie, Carlie S. Sigel, Michael Doukas, Lindsay Alpert, and Thomas J. Fuchs
• Abstract summary: EPIC-Survival bridges encoding and aggregation into an end-to-end survival modelling approach. We show that EPIC-Survival performs better than other approaches in modelling intrahepatic cholangiocarcinoma.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Histopathology-based survival modelling has two major hurdles. Firstly, a well-performing survival model has minimal clinical application if it does not contribute to the stratification of a cancer patient cohort into different risk groups, preferably driven by histologic morphologies. In the clinical setting, individuals are not given specific prognostic predictions, but are rather predicted to lie within a risk group which has a general survival trend. Thus, It is imperative that a survival model produces well-stratified risk groups. Secondly, until now, survival modelling was done in a two-stage approach (encoding and aggregation). The massive amount of pixels in digitized whole slide images were never utilized to their fullest extent due to technological constraints on data processing, forcing decoupled learning. EPIC-Survival bridges encoding and aggregation into an end-to-end survival modelling approach, while introducing stratification boosting to encourage the model to not only optimize ranking, but also to discriminate between risk groups. In this study we show that EPIC-Survival performs better than other approaches in modelling intrahepatic cholangiocarcinoma, a historically difficult cancer to model. Further, we show that stratification boosting improves further improves model performance, resulting in a concordance-index of 0.880 on a held-out test set. Finally, we were able to identify specific histologic differences, not commonly sought out in ICC, between low and high risk groups.

Related papers

• Predicting Deterioration in Mild Cognitive Impairment with Survival Transformers, Extreme Gradient Boosting and Cox Proportional Hazard Modelling [0.08399688944263844]
  The paper proposes a novel approach of survival transformers and extreme gradient boosting models in predicting cognitive deterioration. The proposed approach highlights the potential of these techniques for more accurate early detection and intervention in Alzheimer's dementia disease.
  arXiv  Detail & Related papers  (2024-09-24T16:49:43Z)
• A Multimodal Object-level Contrast Learning Method for Cancer Survival Risk Prediction [9.005219442274344]
  Computer-aided cancer survival risk prediction plays an important role in the timely treatment of patients. We propose a new training method, multimodal object-level contrast learning, for cancer survival risk prediction. The survival risk predictor trained by our proposed method outperforms state-of-the-art methods on two public multimodal cancer datasets.
  arXiv  Detail & Related papers  (2024-09-03T07:36:34Z)
• Comparison of static and dynamic random forests models for EHR data in the presence of competing risks: predicting central line-associated bloodstream infection [2.202802833281752]
  Prognostic outcomes related to hospital admissions typically do not suffer from censoring, and can be modeled either categorically or as time-to-event. We compared the performance of random forest (RF) models to predict the risk of central line-associated bloodstream infections (CLABSI) using different outcome operationalizations.
  arXiv  Detail & Related papers  (2024-04-24T18:31:48Z)
• Deep Neural Networks integrating genomics and histopathological images for predicting stages and survival time-to-event in colon cancer [2.338833859812519]
  We build an ensemble deep neural network for colon cancer stages classification and samples stratification into low or high risk survival groups. The results of our Ensemble Deep Conal Neural Network model show an improved performance in stages classification on the integrated dataset. Among the 2548 fused features, 1695 features showed a statistically significant survival probability differences between the two risk groups defined by the extracted features.
  arXiv  Detail & Related papers  (2022-12-13T16:12:45Z)
• Learning Clinical Concepts for Predicting Risk of Progression to Severe COVID-19 [17.781861866125023]
  Using data from a major healthcare provider, we develop survival models predicting severe COVID-19 progression. We develop two sets of high-performance risk scores: (i) an unconstrained model built from all available features; and (ii) a pipeline that learns a small set of clinical concepts before training a risk predictor.
  arXiv  Detail & Related papers  (2022-08-28T02:59:35Z)
• FastCPH: Efficient Survival Analysis for Neural Networks [57.03275837523063]
  We propose FastCPH, a new method that runs in linear time and supports both the standard Breslow and Efron methods for tied events. We also demonstrate the performance of FastCPH combined with LassoNet, a neural network that provides interpretability through feature sparsity.
  arXiv  Detail & Related papers  (2022-08-21T03:35:29Z)
• SurvLatent ODE : A Neural ODE based time-to-event model with competing risks for longitudinal data improves cancer-associated Deep Vein Thrombosis (DVT) prediction [68.8204255655161]
  We propose a generative time-to-event model, SurvLatent ODE, which parameterizes a latent representation under irregularly sampled data. Our model then utilizes the latent representation to flexibly estimate survival times for multiple competing events without specifying shapes of event-specific hazard function. SurvLatent ODE outperforms the current clinical standard Khorana Risk scores for stratifying DVT risk groups.
  arXiv  Detail & Related papers  (2022-04-20T17:28:08Z)
• A Twin Neural Model for Uplift [59.38563723706796]
  Uplift is a particular case of conditional treatment effect modeling. We propose a new loss function defined by leveraging a connection with the Bayesian interpretation of the relative risk. We show our proposed method is competitive with the state-of-the-art in simulation setting and on real data from large scale randomized experiments.
  arXiv  Detail & Related papers  (2021-05-11T16:02:39Z)
• Bootstrapping Your Own Positive Sample: Contrastive Learning With Electronic Health Record Data [62.29031007761901]
  This paper proposes a novel contrastive regularized clinical classification model. We introduce two unique positive sampling strategies specifically tailored for EHR data. Our framework yields highly competitive experimental results in predicting the mortality risk on real-world COVID-19 EHR data.
  arXiv  Detail & Related papers  (2021-04-07T06:02:04Z)
• Many-to-One Distribution Learning and K-Nearest Neighbor Smoothing for Thoracic Disease Identification [83.6017225363714]
  deep learning has become the most powerful computer-aided diagnosis technology for improving disease identification performance. For chest X-ray imaging, annotating large-scale data requires professional domain knowledge and is time-consuming. In this paper, we propose many-to-one distribution learning (MODL) and K-nearest neighbor smoothing (KNNS) methods to improve a single model's disease identification performance.
  arXiv  Detail & Related papers  (2021-02-26T02:29:30Z)
• A General Framework for Survival Analysis and Multi-State Modelling [70.31153478610229]
  We use neural ordinary differential equations as a flexible and general method for estimating multi-state survival models. We show that our model exhibits state-of-the-art performance on popular survival data sets and demonstrate its efficacy in a multi-state setting.
  arXiv  Detail & Related papers  (2020-06-08T19:24:54Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.